Navicixizumab Antibody
Navicixizumab (OMP-305B83) is a bispecific antibody that inhibits VEGF and DLL4, used in cancer research. It has been studied in combination with paclitaxel for ovarian, primary peritoneal, and fallopian tube cancers, showing activity in both in vitro and in vivo models.
Product Specifications
Target
Gamma-secretase
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
